COHANCE

Cohance Lifesciences Shareholding Pattern

₹454.40-0.57%
Market cap
₹17,384 crore
P/E
163.6
P/B
4.44
ROE
4.7%
Dividend yield
1.20%

As of 30-JUN-2026, promoters held 57.49% of Cohance Lifesciences (0.00 pp from 31-MAR-2026), foreign institutional investors 6.50%, domestic institutions 20.09%, the government 0.01% and the public 15.92%.

Cohance Lifesciences shareholding pattern

Percentage of shares held, by quarter, newest first.

Cohance Lifesciences shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202509-MAY-2025Change
Promoters57.49%57.49%57.49%57.49%66.41%n/a0.00 pp
Foreign institutions (FII/FPI)6.50%5.59%6.02%6.51%7.23%n/a+0.91 pp
Domestic institutions (DII)20.09%21.79%21.57%20.82%11.40%n/a-1.70 pp
Government0.01%0.01%0.01%0.01%0.01%n/a0.00 pp
Public15.92%15.12%14.92%15.17%14.95%n/a+0.80 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Cohance Lifesciences shareholding pattern — frequently asked questions

What is the promoter holding in Cohance Lifesciences?

Promoters held 57.49% of Cohance Lifesciences as of 30-JUN-2026, unchanged from 57.49% in 31-MAR-2026.

How much do FIIs hold in Cohance Lifesciences?

Foreign institutional investors held 6.50% of Cohance Lifesciences as of 30-JUN-2026, a change of +0.91 pp from the previous quarter.

How much do domestic institutions hold in Cohance Lifesciences?

Domestic institutional investors, including mutual funds and insurers, held 20.09% of Cohance Lifesciences as of 30-JUN-2026 (-1.70 pp from the previous quarter).

Who owns Cohance Lifesciences?

As of 30-JUN-2026, Cohance Lifesciences' shareholders were promoters (57.49%), foreign institutional investors 6.50%, domestic institutions 20.09%, the government 0.01% and the public 15.92%, as filed with the stock exchanges.

Same Data For Peers

Trade Cohance Lifesciences With ATS

Track COHANCE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.